<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6266764</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">30532703</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6266764</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fnagi.2018.00388</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Subject characteristics.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p>Subject characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Controls (<italic>n</italic> = 27)</th><th align="center" rowspan="1" colspan="1">Patients (<italic>n</italic> = 24)</th><th align="center" rowspan="1" colspan="1">Statistics</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age in years (<italic>M</italic>, <italic>SD</italic>)</td><td align="center" rowspan="1" colspan="1">59.37 (8.54)</td><td align="center" rowspan="1" colspan="1">63.42 (7.93)</td><td align="center" rowspan="1" colspan="1"><italic>t</italic><sub>(49)</sub> = −1.749,</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.087</td></tr><tr><td align="left" rowspan="1" colspan="1">Education level according</td><td align="center" rowspan="1" colspan="1">6 (3)</td><td align="center" rowspan="1" colspan="1">5 (4)</td><td align="center" rowspan="1" colspan="1"><italic>U</italic> = 174.50,</td></tr><tr><td align="left" rowspan="1" colspan="1">to the Verhage-system</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">(<italic>Mdn</italic>, range)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex</td><td align="center" rowspan="1" colspan="1">11 females</td><td align="center" rowspan="1" colspan="1">7 females</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M1"><mml:mrow><mml:msubsup><mml:mi>χ</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.745,</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.558</td></tr><tr><td align="left" rowspan="1" colspan="1">Disease duration in years</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">4.08 (3.13)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">(M, <italic>SD</italic>)</td></tr><tr><td align="left" rowspan="1" colspan="1">LEDD in mg (<italic>M</italic>, <italic>SD</italic>)*</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">796.29 (616.44)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">UPDRS during OFF phase</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">21.08 (8.31)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">(M, SD)</td></tr><tr><td align="left" rowspan="1" colspan="1">MoCA (<italic>M</italic>, <italic>SD</italic>)</td><td align="center" rowspan="1" colspan="1">27.89 (1.89)</td><td align="center" rowspan="1" colspan="1">26.88 (1.92)</td><td align="center" rowspan="1" colspan="1"><italic>t</italic><sub>(49)</sub> = 1.90,</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.063</td></tr><tr><td align="left" rowspan="1" colspan="1">BDI</td><td align="center" rowspan="1" colspan="1">22.96 (2.24)</td><td align="center" rowspan="1" colspan="1">30.46 (7.12)</td><td align="center" rowspan="1" colspan="1"><italic>t</italic><sub>(48)</sub> = −4.938,</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic> &lt; 0.001</td></tr></tbody></table><table-wrap-foot><p><italic>LEDD, Levodopa Equivalent Daily Dose; MoCA, Montreal Cognitive Assessment; BDI, Beck’s Depression Inventory. *Twelve patients received Levodopa monotherapy, all other patients were taking a combination of Levodopa with DA-agonists or MAO-B/COMT- inhibitors</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Subject characteristics.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th align="center">Controls (n = 27)</th><th align="center">Patients (n = 24)</th><th align="center">Statistics</th></tr></thead><tbody><tr><td align="left">Age in years (M, SD)</td><td align="center">59.37 (8.54)</td><td align="center">63.42 (7.93)</td><td align="center">t(49) = −1.749,</td></tr><tr><td/><td/><td/><td align="center">p = 0.087</td></tr><tr><td align="left">Education level according</td><td align="center">6 (3)</td><td align="center">5 (4)</td><td align="center">U = 174.50,</td></tr><tr><td align="left">to the Verhage-system</td><td/><td/><td align="center">p = 0.003</td></tr><tr><td align="left">(Mdn, range)</td></tr><tr><td align="left">Sex</td><td align="center">11 females</td><td align="center">7 females</td><td align="center"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:msubsup><mml:mi>χ</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math> = 0.745,</td></tr><tr><td/><td/><td/><td align="center">p = 0.558</td></tr><tr><td align="left">Disease duration in years</td><td align="center">-</td><td align="center">4.08 (3.13)</td><td align="center">-</td></tr><tr><td align="left">(M, SD)</td></tr><tr><td align="left">LEDD in mg (M, SD)*</td><td align="center">-</td><td align="center">796.29 (616.44)</td><td align="center">-</td></tr><tr><td align="left">UPDRS during OFF phase</td><td align="center">-</td><td align="center">21.08 (8.31)</td><td align="center">-</td></tr><tr><td align="left">(M, SD)</td></tr><tr><td align="left">MoCA (M, SD)</td><td align="center">27.89 (1.89)</td><td align="center">26.88 (1.92)</td><td align="center">t(49) = 1.90,</td></tr><tr><td/><td/><td/><td align="center">p = 0.063</td></tr><tr><td align="left">BDI</td><td align="center">22.96 (2.24)</td><td align="center">30.46 (7.12)</td><td align="center">t(48) = −4.938,</td></tr><tr><td/><td/><td/><td align="center">p &lt; 0.001</td></tr></tbody></table></div>LEDD, Levodopa Equivalent Daily Dose; MoCA, Montreal Cognitive Assessment; BDI, Beck’s Depression Inventory. *Twelve patients received Levodopa monotherapy, all other patients were taking a combination of Levodopa with DA-agonists or MAO-B/COMT- inhibitors.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2</table-label><table-caption>Group differences in cognitive performance.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2</label><caption><p>Group differences in cognitive performance.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Controls <italic>M</italic> (<italic>SD</italic>)</th><th align="center" rowspan="1" colspan="1">Patients <italic>M</italic> (<italic>SD</italic>)</th><th align="center" rowspan="1" colspan="1">Statistics</th><th align="center" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CFR</td><td align="center" rowspan="1" colspan="1">24.37 (4.98)</td><td align="center" rowspan="1" colspan="1">18.56 (7.32)</td><td align="center" rowspan="1" colspan="1"><italic>t</italic><sub>(45)</sub> = 3.17</td><td align="center" rowspan="1" colspan="1">0.003*</td></tr><tr><td align="left" rowspan="1" colspan="1">AVLT immediate recall</td><td align="center" rowspan="1" colspan="1">44.48 (11.48)</td><td align="center" rowspan="1" colspan="1">37.33 (8.28)</td><td align="center" rowspan="1" colspan="1"><italic>t</italic><sub>(49)</sub> = 2.52</td><td align="center" rowspan="1" colspan="1">0.015*</td></tr><tr><td align="left" rowspan="1" colspan="1">AVLT delayed recall</td><td align="center" rowspan="1" colspan="1">9.26 (3.60)</td><td align="center" rowspan="1" colspan="1">6.88 (2.54)</td><td align="center" rowspan="1" colspan="1"><italic>t</italic><sub>(46.72)</sub> = 2.75</td><td align="center" rowspan="1" colspan="1">0.008*</td></tr><tr><td align="left" rowspan="1" colspan="1">Fluency</td><td align="center" rowspan="1" colspan="1">19.70 (3.11)</td><td align="center" rowspan="1" colspan="1">16.94 (4.04)</td><td align="center" rowspan="1" colspan="1"><italic>t</italic><sub>(49)</sub> = 2.74</td><td align="center" rowspan="1" colspan="1">0.008*</td></tr><tr><td align="left" rowspan="1" colspan="1">BADS rule shift</td><td align="center" rowspan="1" colspan="1">32.44 (10.00)</td><td align="center" rowspan="1" colspan="1">37.04 (13.61)</td><td align="center" rowspan="1" colspan="1"><italic>U</italic> = 273.5</td><td align="center" rowspan="1" colspan="1">0.402</td></tr><tr><td align="left" rowspan="1" colspan="1">Digitspan backwards</td><td align="center" rowspan="1" colspan="1">6.85 (2.10)</td><td align="center" rowspan="1" colspan="1">6.33 (2.33)</td><td align="center" rowspan="1" colspan="1"><italic>t</italic><sub>(49)</sub> = 0.841</td><td align="center" rowspan="1" colspan="1">0.405</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroop (interference)</td><td align="center" rowspan="1" colspan="1">0.66 (0.10)</td><td align="center" rowspan="1" colspan="1">0.62 (0.11)</td><td align="center" rowspan="1" colspan="1"><italic>t</italic><sub>(49)</sub> = 1.22</td><td align="center" rowspan="1" colspan="1">0.227</td></tr></tbody></table><table-wrap-foot><p><italic>AVLT, Auditory Verbal Learning Test; BADS, Behavioral Assessment of the Dysexecutive Syndrome; CFR, Complex Figure of Rey. *Significant, corrected using the False Discovery Rate</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Group differences in cognitive performance.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th align="center">Controls M (SD)</th><th align="center">Patients M (SD)</th><th align="center">Statistics</th><th align="center">p-value</th></tr></thead><tbody><tr><td align="left">CFR</td><td align="center">24.37 (4.98)</td><td align="center">18.56 (7.32)</td><td align="center">t(45) = 3.17</td><td align="center">0.003*</td></tr><tr><td align="left">AVLT immediate recall</td><td align="center">44.48 (11.48)</td><td align="center">37.33 (8.28)</td><td align="center">t(49) = 2.52</td><td align="center">0.015*</td></tr><tr><td align="left">AVLT delayed recall</td><td align="center">9.26 (3.60)</td><td align="center">6.88 (2.54)</td><td align="center">t(46.72) = 2.75</td><td align="center">0.008*</td></tr><tr><td align="left">Fluency</td><td align="center">19.70 (3.11)</td><td align="center">16.94 (4.04)</td><td align="center">t(49) = 2.74</td><td align="center">0.008*</td></tr><tr><td align="left">BADS rule shift</td><td align="center">32.44 (10.00)</td><td align="center">37.04 (13.61)</td><td align="center">U = 273.5</td><td align="center">0.402</td></tr><tr><td align="left">Digitspan backwards</td><td align="center">6.85 (2.10)</td><td align="center">6.33 (2.33)</td><td align="center">t(49) = 0.841</td><td align="center">0.405</td></tr><tr><td align="left">Stroop (interference)</td><td align="center">0.66 (0.10)</td><td align="center">0.62 (0.11)</td><td align="center">t(49) = 1.22</td><td align="center">0.227</td></tr></tbody></table></div>AVLT, Auditory Verbal Learning Test; BADS, Behavioral Assessment of the Dysexecutive Syndrome; CFR, Complex Figure of Rey. *Significant, corrected using the False Discovery Rate.</transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>Table 3</table-label><table-caption>Association between dynamic functional connectivity (dFC) and cognitive functioning.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T3" position="float"><label>Table 3</label><caption><p>Association between dynamic functional connectivity (dFC) and cognitive functioning.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Network</th><th align="left" rowspan="1" colspan="1">Cognitive measure</th><th align="center" rowspan="1" colspan="1">Unstandardized B</th><th align="center" rowspan="1" colspan="1">Std. error of B</th><th align="center" rowspan="1" colspan="1">Standardized Beta</th><th align="center" rowspan="1" colspan="1"><italic>p</italic>-value</th><th align="center" rowspan="1" colspan="1">Effect size (<italic>R</italic><sup>2</sup> change)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DMN</td><td align="left" rowspan="1" colspan="1">CFR</td><td align="center" rowspan="1" colspan="1">0.974</td><td align="center" rowspan="1" colspan="1">0.398</td><td align="center" rowspan="1" colspan="1">0.502</td><td align="center" rowspan="1" colspan="1">0.023*</td><td align="center" rowspan="1" colspan="1">0.219</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AVLT immediate</td><td align="center" rowspan="1" colspan="1">0.464</td><td align="center" rowspan="1" colspan="1">0.491</td><td align="center" rowspan="1" colspan="1">0.212</td><td align="center" rowspan="1" colspan="1">0.356</td><td align="center" rowspan="1" colspan="1">0.039</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AVLT delayed</td><td align="center" rowspan="1" colspan="1">0.214</td><td align="center" rowspan="1" colspan="1">0.151</td><td align="center" rowspan="1" colspan="1">0.317</td><td align="center" rowspan="1" colspan="1">0.171</td><td align="center" rowspan="1" colspan="1">0.039</td></tr><tr><td align="left" rowspan="1" colspan="1">FPN</td><td align="left" rowspan="1" colspan="1">Verbal fluency</td><td align="center" rowspan="1" colspan="1">0.405</td><td align="center" rowspan="1" colspan="1">0.267</td><td align="center" rowspan="1" colspan="1">0.305</td><td align="center" rowspan="1" colspan="1">0.145</td><td align="center" rowspan="1" colspan="1">0.083</td></tr></tbody></table><table-wrap-foot><p><italic>Linear hierarchical regression analyses were performed with a forward stepwise method, per cognitive outcome measure. DMN, Default Mode Network; FPN, Frontoparietal Network; CFR, Complex Figure of Rey; AVLT, Auditory Verbal Learning Test; *significant association</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Association between dynamic functional connectivity (dFC) and cognitive functioning.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left">Network</th><th align="left">Cognitive measure</th><th align="center">Unstandardized B</th><th align="center">Std. error of B</th><th align="center">Standardized Beta</th><th align="center">p-value</th><th align="center">Effect size (R2 change)</th></tr></thead><tbody><tr><td align="left">DMN</td><td align="left">CFR</td><td align="center">0.974</td><td align="center">0.398</td><td align="center">0.502</td><td align="center">0.023*</td><td align="center">0.219</td></tr><tr><td/><td align="left">AVLT immediate</td><td align="center">0.464</td><td align="center">0.491</td><td align="center">0.212</td><td align="center">0.356</td><td align="center">0.039</td></tr><tr><td/><td align="left">AVLT delayed</td><td align="center">0.214</td><td align="center">0.151</td><td align="center">0.317</td><td align="center">0.171</td><td align="center">0.039</td></tr><tr><td align="left">FPN</td><td align="left">Verbal fluency</td><td align="center">0.405</td><td align="center">0.267</td><td align="center">0.305</td><td align="center">0.145</td><td align="center">0.083</td></tr></tbody></table></div>Linear hierarchical regression analyses were performed with a forward stepwise method, per cognitive outcome measure. DMN, Default Mode Network; FPN, Frontoparietal Network; CFR, Complex Figure of Rey; AVLT, Auditory Verbal Learning Test; *significant association.</transformed-table></extracted-table><extracted-table><table-id>T4</table-id><table-label>Table 4</table-label><table-caption>Association between dFC, pain and motor symptoms.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T4" position="float"><label>Table 4</label><caption><p>Association between dFC, pain and motor symptoms.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Unstandardized B</th><th align="center" rowspan="1" colspan="1">Std. error of B</th><th align="center" rowspan="1" colspan="1">Standardized B</th><th align="center" rowspan="1" colspan="1"><italic>p</italic>-value</th><th align="center" rowspan="1" colspan="1">Effect size (<italic>R</italic><sup>2</sup>)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DMN</td><td align="left" rowspan="1" colspan="1">Motor severity:</td><td align="left" rowspan="1" colspan="1">UPDRS III</td><td align="center" rowspan="1" colspan="1">−0.301</td><td align="center" rowspan="1" colspan="1">0.510</td><td align="center" rowspan="1" colspan="1">−0.137</td><td align="center" rowspan="1" colspan="1">0.562</td><td align="center" rowspan="1" colspan="1">0.016</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Pain experience:</td><td align="left" rowspan="1" colspan="1">NRS</td><td align="center" rowspan="1" colspan="1">−0.121</td><td align="center" rowspan="1" colspan="1">0.140</td><td align="center" rowspan="1" colspan="1">−0.198</td><td align="center" rowspan="1" colspan="1">0.398</td><td align="center" rowspan="1" colspan="1">0.034</td></tr><tr><td align="left" rowspan="1" colspan="1">FPN</td><td align="left" rowspan="1" colspan="1">Motor severity:</td><td align="left" rowspan="1" colspan="1">UPDRS III</td><td align="center" rowspan="1" colspan="1">0.239</td><td align="center" rowspan="1" colspan="1">0.250</td><td align="center" rowspan="1" colspan="1">0.216</td><td align="center" rowspan="1" colspan="1">0.350</td><td align="center" rowspan="1" colspan="1">0.042</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Pain experience:</td><td align="left" rowspan="1" colspan="1">NRS</td><td align="center" rowspan="1" colspan="1">0.009</td><td align="center" rowspan="1" colspan="1">0.071</td><td align="center" rowspan="1" colspan="1">0.031</td><td align="center" rowspan="1" colspan="1">0.896</td><td align="center" rowspan="1" colspan="1">0.001</td></tr></tbody></table><table-wrap-foot><p><italic>Linear hierarchical regression analyses were performed with a forward stepwise method, per symptom</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 4<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Association between dFC, pain and motor symptoms.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th align="center">Unstandardized B</th><th align="center">Std. error of B</th><th align="center">Standardized B</th><th align="center">p-value</th><th align="center">Effect size (R2)</th></tr></thead><tbody><tr><td align="left">DMN</td><td align="left">Motor severity:</td><td align="left">UPDRS III</td><td align="center">−0.301</td><td align="center">0.510</td><td align="center">−0.137</td><td align="center">0.562</td><td align="center">0.016</td></tr><tr><td/><td align="left">Pain experience:</td><td align="left">NRS</td><td align="center">−0.121</td><td align="center">0.140</td><td align="center">−0.198</td><td align="center">0.398</td><td align="center">0.034</td></tr><tr><td align="left">FPN</td><td align="left">Motor severity:</td><td align="left">UPDRS III</td><td align="center">0.239</td><td align="center">0.250</td><td align="center">0.216</td><td align="center">0.350</td><td align="center">0.042</td></tr><tr><td/><td align="left">Pain experience:</td><td align="left">NRS</td><td align="center">0.009</td><td align="center">0.071</td><td align="center">0.031</td><td align="center">0.896</td><td align="center">0.001</td></tr></tbody></table></div>Linear hierarchical regression analyses were performed with a forward stepwise method, per symptom.</transformed-table></extracted-table></extracted-tables-set>